Planet 13 Holdings Inc banner
P

Planet 13 Holdings Inc
CNSX:PLTH

Watchlist Manager
Planet 13 Holdings Inc
CNSX:PLTH
Watchlist
Price: 0.215 CAD 2.38%
Market Cap: CA$70m

Multiples-Based Value

The Multiples-Based Value for Planet 13 Holdings Inc (PLTH) under the Base Case is hidden CAD. Compared with the current market price of 0.215 CAD, the stock appears hidden .

Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

PLTH Multiples-Based Value
LOCKED
Unlock
Worst Case
Base Case
Best Case

Multiples Across Competitors

PLTH Competitors Multiples
Planet 13 Holdings Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Planet 13 Holdings Inc
CNSX:PLTH
70m CAD 0.5 -0.6 -1.8 -1.1
US
Eli Lilly and Co
NYSE:LLY
883.9B USD 13.4 42.4 28.6 30.5
US
Johnson & Johnson
NYSE:JNJ
585.2B USD 6.2 21.7 15.1 18.5
UK
AstraZeneca PLC
LSE:AZN
237.5B GBP 5.4 31.2 17.2 24.2
CH
Roche Holding AG
SIX:ROG
248.4B CHF 4.1 19.7 11.6 13.1
US
Merck & Co Inc
NYSE:MRK
299.1B USD 4.6 16.3 10.1 12.3
CH
Novartis AG
SIX:NOVN
236.4B CHF 5.4 21.8 13.5 17.3
IE
Endo International PLC
LSE:0Y5F
244.4B USD 105.4 -83.6 386.8 970
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK 3.4 10.3 7.6 9
US
Pfizer Inc
NYSE:PFE
161B USD 2.5 20.5 7.8 10.4
US
Bristol-Myers Squibb Co
NYSE:BMY
120B USD 2.5 16.9 7.1 8.8
P/E Multiple
Earnings Growth PEG
US
P
Planet 13 Holdings Inc
CNSX:PLTH
Average P/E: 22.3
Negative Multiple: -0.6
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
42.4
32%
1.3
US
Johnson & Johnson
NYSE:JNJ
21.7
7%
3.1
UK
AstraZeneca PLC
LSE:AZN
31.2
26%
1.2
CH
Roche Holding AG
SIX:ROG
19.7
14%
1.4
US
Merck & Co Inc
NYSE:MRK
16.3
14%
1.2
CH
Novartis AG
SIX:NOVN
21.8
14%
1.6
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -83.6 N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
10.3
1%
10.3
US
Pfizer Inc
NYSE:PFE
20.5
22%
0.9
US
Bristol-Myers Squibb Co
NYSE:BMY
16.9
16%
1.1
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
P
Planet 13 Holdings Inc
CNSX:PLTH
Average EV/EBITDA: 50.6
Negative Multiple: -1.8
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
28.6
22%
1.3
US
Johnson & Johnson
NYSE:JNJ
15.1
2%
7.5
UK
AstraZeneca PLC
LSE:AZN
17.2
13%
1.3
CH
Roche Holding AG
SIX:ROG
11.6
6%
1.9
US
Merck & Co Inc
NYSE:MRK
10.1
3%
3.4
CH
Novartis AG
SIX:NOVN
13.5
5%
2.7
IE
E
Endo International PLC
LSE:0Y5F
386.8
N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
7.6
1%
7.6
US
Pfizer Inc
NYSE:PFE
7.8
-9%
N/A
US
Bristol-Myers Squibb Co
NYSE:BMY
7.1
-10%
N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
P
Planet 13 Holdings Inc
CNSX:PLTH
Average EV/EBIT: 111.4
Negative Multiple: -1.1
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
30.5
22%
1.4
US
Johnson & Johnson
NYSE:JNJ
18.5
6%
3.1
UK
AstraZeneca PLC
LSE:AZN
24.2
21%
1.2
CH
Roche Holding AG
SIX:ROG
13.1
6%
2.2
US
Merck & Co Inc
NYSE:MRK
12.3
6%
2
CH
Novartis AG
SIX:NOVN
17.3
9%
1.9
IE
E
Endo International PLC
LSE:0Y5F
970
N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
9
2%
4.5
US
Pfizer Inc
NYSE:PFE
10.4
-4%
N/A
US
Bristol-Myers Squibb Co
NYSE:BMY
8.8
-7%
N/A
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett